Results for apex translation from Slovak to Maltese

Human contributions

From professional translators, enterprises, web pages and freely available translation repositories.

Add a translation

Slovak

Maltese

Info

Slovak

apex

Maltese

120 mg qd 65% *, #

Last Update: 2011-10-23
Usage Frequency: 1
Quality:

Warning: This alignment may be wrong.
Please delete it you feel so.

Slovak

Štúdia apex:

Maltese

studju apex:

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Slovak

apex -*nl x --(mod.)(16) -

Maltese

apex -*nl x --(mod.)(16) -

Last Update: 2008-03-04
Usage Frequency: 1
Quality:

Reference: Anonymous

Slovak

(10 pacientov z 268 v štúdii apex).

Maltese

(10 pazjenti minn 268 fl- istudju apex).

Last Update: 2012-04-11
Usage Frequency: 2
Quality:

Reference: Anonymous

Slovak

percento pacientov, ktorí vyžadovali liečbu kvôli vzplanutiu dnavého záchvatu (štúdia apex a fact) bolo číselne nižšie v skupinách, ktoré dosiahli priemernú neskoršiu koncentráciu urátov v sére < 6, 0 mg/ dl, < 5, 0 mg/ dl, alebo < 4, 0 mg/ dl v porovnaní so skupinou, ktorá dosiahla priemernú neskoršiu koncentráciu urátov v sére ≥6, 0 mg/ dl počas posledných 32 týždňov obdobia liečby (intervaly 20. týždeň – 24. týždeň až 48 – 52. týždeň).

Maltese

riżultati kliniċi: proporzjon ta ’ pazjenti li kellhom bżonn kura għall- irkadar tal- gotta u bidla fid- daqs tat- tofi il- proporzjon ta ’ individwi li kellhom bżonn kura għall- irkadar tal- gotta (studju apex u fact) kien numerikament aktar baxx fil- gruppi li laħqu livell medju ta ’ urate fis- serum wara l- linja bażi ta ’ < 6. 0 mg/ dl, < 5. 0 mg/ dl, jew < 4. 0 mg/ dl meta mqabbel mal- grupp li laħaq livell medju ta ’ urate fis- serum wara l- linja bażi ta ’ ≥6. 0 mg/ dl waqt l- aħħar 32 ġimgħa tal- perjodu ta ’ kura (intervalli Ġimgħa 20 - Ġimgħa 24 sa Ġimgħa 48 - 52).

Last Update: 2012-04-11
Usage Frequency: 4
Quality:

Reference: Anonymous
Warning: Contains invisible HTML formatting

Get a better translation with
8,647,698,518 human contributions

Users are now asking for help:



We use cookies to enhance your experience. By continuing to visit this site you agree to our use of cookies. Learn more. OK